Mark T. Stautberg
Directeur/Bestuurslid bij Xenter, Inc.
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
James Tobin | M | 79 |
Xenter, Inc.
Xenter, Inc. Electronic Equipment/InstrumentsElectronic Technology Xenter, Inc. is a privately held, investor-backed company that has launched a wireless techmed ecosystem designed to provide transformative outcomes for physicians, healthcare professionals, provider organizations, and patients. Xenter is headquartered in Draper, UT and was formed in 2020. The company's trademarks include xenter, xenfi, xmd, xenfi-hub, xmd, and physical intelligence. The company was founded by Richard J. Linder and he has been the CEO since incorporation. | 11 jaar |
Michael Mahoney | M | 59 | 13 jaar | |
Richard J. Linder | M | - |
Xenter, Inc.
Xenter, Inc. Electronic Equipment/InstrumentsElectronic Technology Xenter, Inc. is a privately held, investor-backed company that has launched a wireless techmed ecosystem designed to provide transformative outcomes for physicians, healthcare professionals, provider organizations, and patients. Xenter is headquartered in Draper, UT and was formed in 2020. The company's trademarks include xenter, xenfi, xmd, xenfi-hub, xmd, and physical intelligence. The company was founded by Richard J. Linder and he has been the CEO since incorporation. | 7 jaar |
Jonathan Monson | M | 50 | 16 jaar | |
Vance Brown | M | 54 | 23 jaar | |
Lauren Tengler | F | - | 24 jaar | |
John Sununu | M | 59 | 15 jaar | |
Mary Moynihan | F | 57 | 27 jaar | |
John Sorenson | M | 56 | 22 jaar | |
Daniel Brennan | M | 58 | 28 jaar | |
Brenda Becker | F | 64 | 17 jaar | |
Robert Baxter | M | - |
Xenter, Inc.
Xenter, Inc. Electronic Equipment/InstrumentsElectronic Technology Xenter, Inc. is a privately held, investor-backed company that has launched a wireless techmed ecosystem designed to provide transformative outcomes for physicians, healthcare professionals, provider organizations, and patients. Xenter is headquartered in Draper, UT and was formed in 2020. The company's trademarks include xenter, xenfi, xmd, xenfi-hub, xmd, and physical intelligence. The company was founded by Richard J. Linder and he has been the CEO since incorporation. | 4 jaar |
David J. Bearss | M | 55 |
Xenter, Inc.
Xenter, Inc. Electronic Equipment/InstrumentsElectronic Technology Xenter, Inc. is a privately held, investor-backed company that has launched a wireless techmed ecosystem designed to provide transformative outcomes for physicians, healthcare professionals, provider organizations, and patients. Xenter is headquartered in Draper, UT and was formed in 2020. The company's trademarks include xenter, xenfi, xmd, xenfi-hub, xmd, and physical intelligence. The company was founded by Richard J. Linder and he has been the CEO since incorporation. | 3 jaar |
Elazer Edelman | M | 67 |
Xenter, Inc.
Xenter, Inc. Electronic Equipment/InstrumentsElectronic Technology Xenter, Inc. is a privately held, investor-backed company that has launched a wireless techmed ecosystem designed to provide transformative outcomes for physicians, healthcare professionals, provider organizations, and patients. Xenter is headquartered in Draper, UT and was formed in 2020. The company's trademarks include xenter, xenfi, xmd, xenfi-hub, xmd, and physical intelligence. The company was founded by Richard J. Linder and he has been the CEO since incorporation. | 3 jaar |
Wendy Carruthers | F | 55 | 20 jaar | |
Kenneth Stein | M | - | 15 jaar | |
Arthur Butcher | M | 53 | 28 jaar | |
Mark Bickel | M | - | 17 jaar | |
Michael Jones | M | - | 29 jaar | |
Milad Girgis | M | - | 20 jaar | |
Charlie Attlan | M | - | 14 jaar | |
Colin Morrison | M | - | 22 jaar | |
Robert Langer | M | 74 |
Xenter, Inc.
Xenter, Inc. Electronic Equipment/InstrumentsElectronic Technology Xenter, Inc. is a privately held, investor-backed company that has launched a wireless techmed ecosystem designed to provide transformative outcomes for physicians, healthcare professionals, provider organizations, and patients. Xenter is headquartered in Draper, UT and was formed in 2020. The company's trademarks include xenter, xenfi, xmd, xenfi-hub, xmd, and physical intelligence. The company was founded by Richard J. Linder and he has been the CEO since incorporation. | 3 jaar |
Eric Francis Thepaut | M | 62 | 28 jaar | |
Jeffrey Mirviss | M | 58 | 27 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Jean Fitterer Lance | F | 62 | - | |
Timothy A. Pratt | M | 74 | 9 jaar | |
William Hank Kucheman | M | 74 | 16 jaar | |
Richard D. Randall | M | 72 |
TranS1, Inc.
TranS1, Inc. Medical SpecialtiesHealth Technology TranS1, Inc. designs and develops surgical procedures and equipment for back pain. It is a medical device company focused on designing, developing and marketing products that implement its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region. TranS1 currently markets the AxiaLIF family of products for single-level and two-level lumbar fusion and the Vectre and Avatar posterior fixation systems for lumbar fixation supplemental to AxiaLIF fusion. Its primary technology is AxiaLIF, a minimally invasive access and fusion system that enables lumbar fusion to be performed with complete preservation of the annulus and all paraspinal soft tissue structures. The company specializes in bringing innovative spine solutions to market, including AxiaLIF and AxiaLIF 2L+, technologies that allow surgeons to perform lower lumbar fusions that result in high fusion rates and low complication rates. The company is also developing a motion preservation platform to be delivered through this minimally invasive, trans-sacral approach. TranS1 was founded in May 2000 and is headquartered in Wilmington, NC. | 11 jaar |
Sam Leno | M | 78 | 4 jaar | |
John Raymond Elliott | M | 74 | 3 jaar | |
Kristina Johnson | M | 67 | 11 jaar | |
Paul LaViolette | M | 66 |
TranS1, Inc.
TranS1, Inc. Medical SpecialtiesHealth Technology TranS1, Inc. designs and develops surgical procedures and equipment for back pain. It is a medical device company focused on designing, developing and marketing products that implement its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region. TranS1 currently markets the AxiaLIF family of products for single-level and two-level lumbar fusion and the Vectre and Avatar posterior fixation systems for lumbar fixation supplemental to AxiaLIF fusion. Its primary technology is AxiaLIF, a minimally invasive access and fusion system that enables lumbar fusion to be performed with complete preservation of the annulus and all paraspinal soft tissue structures. The company specializes in bringing innovative spine solutions to market, including AxiaLIF and AxiaLIF 2L+, technologies that allow surgeons to perform lower lumbar fusions that result in high fusion rates and low complication rates. The company is also developing a motion preservation platform to be delivered through this minimally invasive, trans-sacral approach. TranS1 was founded in May 2000 and is headquartered in Wilmington, NC. | 19 jaar |
Michael V. Chobotov | M | 63 | 4 jaar | |
Kenneth Reali | M | 58 |
TranS1, Inc.
TranS1, Inc. Medical SpecialtiesHealth Technology TranS1, Inc. designs and develops surgical procedures and equipment for back pain. It is a medical device company focused on designing, developing and marketing products that implement its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region. TranS1 currently markets the AxiaLIF family of products for single-level and two-level lumbar fusion and the Vectre and Avatar posterior fixation systems for lumbar fixation supplemental to AxiaLIF fusion. Its primary technology is AxiaLIF, a minimally invasive access and fusion system that enables lumbar fusion to be performed with complete preservation of the annulus and all paraspinal soft tissue structures. The company specializes in bringing innovative spine solutions to market, including AxiaLIF and AxiaLIF 2L+, technologies that allow surgeons to perform lower lumbar fusions that result in high fusion rates and low complication rates. The company is also developing a motion preservation platform to be delivered through this minimally invasive, trans-sacral approach. TranS1 was founded in May 2000 and is headquartered in Wilmington, NC. | 3 jaar |
Jeffrey Capello | M | 69 | 5 jaar | |
Brian Burns | M | 60 | - | |
Jeffrey Fischgrund | M | 63 |
TranS1, Inc.
TranS1, Inc. Medical SpecialtiesHealth Technology TranS1, Inc. designs and develops surgical procedures and equipment for back pain. It is a medical device company focused on designing, developing and marketing products that implement its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region. TranS1 currently markets the AxiaLIF family of products for single-level and two-level lumbar fusion and the Vectre and Avatar posterior fixation systems for lumbar fixation supplemental to AxiaLIF fusion. Its primary technology is AxiaLIF, a minimally invasive access and fusion system that enables lumbar fusion to be performed with complete preservation of the annulus and all paraspinal soft tissue structures. The company specializes in bringing innovative spine solutions to market, including AxiaLIF and AxiaLIF 2L+, technologies that allow surgeons to perform lower lumbar fusions that result in high fusion rates and low complication rates. The company is also developing a motion preservation platform to be delivered through this minimally invasive, trans-sacral approach. TranS1 was founded in May 2000 and is headquartered in Wilmington, NC. | 1 jaar |
Maulik Nanavaty | M | 62 | - | |
Bobby Dwayne Montgomery | M | 56 |
TranS1, Inc.
TranS1, Inc. Medical SpecialtiesHealth Technology TranS1, Inc. designs and develops surgical procedures and equipment for back pain. It is a medical device company focused on designing, developing and marketing products that implement its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region. TranS1 currently markets the AxiaLIF family of products for single-level and two-level lumbar fusion and the Vectre and Avatar posterior fixation systems for lumbar fixation supplemental to AxiaLIF fusion. Its primary technology is AxiaLIF, a minimally invasive access and fusion system that enables lumbar fusion to be performed with complete preservation of the annulus and all paraspinal soft tissue structures. The company specializes in bringing innovative spine solutions to market, including AxiaLIF and AxiaLIF 2L+, technologies that allow surgeons to perform lower lumbar fusions that result in high fusion rates and low complication rates. The company is also developing a motion preservation platform to be delivered through this minimally invasive, trans-sacral approach. TranS1 was founded in May 2000 and is headquartered in Wilmington, NC. | 3 jaar |
Jon W. Osgood | M | 74 |
TranS1, Inc.
TranS1, Inc. Medical SpecialtiesHealth Technology TranS1, Inc. designs and develops surgical procedures and equipment for back pain. It is a medical device company focused on designing, developing and marketing products that implement its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region. TranS1 currently markets the AxiaLIF family of products for single-level and two-level lumbar fusion and the Vectre and Avatar posterior fixation systems for lumbar fixation supplemental to AxiaLIF fusion. Its primary technology is AxiaLIF, a minimally invasive access and fusion system that enables lumbar fusion to be performed with complete preservation of the annulus and all paraspinal soft tissue structures. The company specializes in bringing innovative spine solutions to market, including AxiaLIF and AxiaLIF 2L+, technologies that allow surgeons to perform lower lumbar fusions that result in high fusion rates and low complication rates. The company is also developing a motion preservation platform to be delivered through this minimally invasive, trans-sacral approach. TranS1 was founded in May 2000 and is headquartered in Wilmington, NC. | 11 jaar |
Kristen Ambrose | F | 47 | 18 jaar | |
Norwick B. H. Goodspeed | M | 74 |
FlowCardia, Inc.
FlowCardia, Inc. Medical SpecialtiesHealth Technology FlowCardia, Inc. designs, develops and manufactures endovascular devices. It offers flowmate Injector to optimize the performance of crosser cto recanalization and crosser catheter, a minimally-invasive endovascular device. The firm also provides portfolio of catheter-based technologies to facilitate guidewire crossing of totally occluded coronary and peripheral arteries. The company was founded by Henry Nita and Erik T. Engelson in 2001 and is headquartered in Sunnyvale, CA. | - |
Geoffrey Rose | M | 50 | 8 jaar | |
Christopher Barys | M | 57 |
FlowCardia, Inc.
FlowCardia, Inc. Medical SpecialtiesHealth Technology FlowCardia, Inc. designs, develops and manufactures endovascular devices. It offers flowmate Injector to optimize the performance of crosser cto recanalization and crosser catheter, a minimally-invasive endovascular device. The firm also provides portfolio of catheter-based technologies to facilitate guidewire crossing of totally occluded coronary and peripheral arteries. The company was founded by Henry Nita and Erik T. Engelson in 2001 and is headquartered in Sunnyvale, CA. | 3 jaar |
Supratim Bose | M | 72 | 7 jaar | |
Milton Morris | M | 54 | 11 jaar | |
Katharine T. Bartlett | F | 77 | - | |
Nelda Connors | F | 58 | 15 jaar | |
David Pierce | M | 61 | 31 jaar | |
John B. Pedersen | M | 61 | - | |
Lawrence R. Neumann | M | 61 | - | |
Michael Berman | M | 66 | 5 jaar | |
David Milne | M | 61 | 6 jaar | |
Michael Carusi | M | 58 |
TranS1, Inc.
TranS1, Inc. Medical SpecialtiesHealth Technology TranS1, Inc. designs and develops surgical procedures and equipment for back pain. It is a medical device company focused on designing, developing and marketing products that implement its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region. TranS1 currently markets the AxiaLIF family of products for single-level and two-level lumbar fusion and the Vectre and Avatar posterior fixation systems for lumbar fixation supplemental to AxiaLIF fusion. Its primary technology is AxiaLIF, a minimally invasive access and fusion system that enables lumbar fusion to be performed with complete preservation of the annulus and all paraspinal soft tissue structures. The company specializes in bringing innovative spine solutions to market, including AxiaLIF and AxiaLIF 2L+, technologies that allow surgeons to perform lower lumbar fusions that result in high fusion rates and low complication rates. The company is also developing a motion preservation platform to be delivered through this minimally invasive, trans-sacral approach. TranS1 was founded in May 2000 and is headquartered in Wilmington, NC. | 10 jaar |
Paul W. Sandman | M | 76 | 15 jaar | |
John Onuscheck | M | 57 | - | |
Scott William Kraus | M | 54 | - | |
Keith Dawkins | M | 73 | 9 jaar | |
David J. Simpson | M | 77 |
TranS1, Inc.
TranS1, Inc. Medical SpecialtiesHealth Technology TranS1, Inc. designs and develops surgical procedures and equipment for back pain. It is a medical device company focused on designing, developing and marketing products that implement its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region. TranS1 currently markets the AxiaLIF family of products for single-level and two-level lumbar fusion and the Vectre and Avatar posterior fixation systems for lumbar fixation supplemental to AxiaLIF fusion. Its primary technology is AxiaLIF, a minimally invasive access and fusion system that enables lumbar fusion to be performed with complete preservation of the annulus and all paraspinal soft tissue structures. The company specializes in bringing innovative spine solutions to market, including AxiaLIF and AxiaLIF 2L+, technologies that allow surgeons to perform lower lumbar fusions that result in high fusion rates and low complication rates. The company is also developing a motion preservation platform to be delivered through this minimally invasive, trans-sacral approach. TranS1 was founded in May 2000 and is headquartered in Wilmington, NC. | 3 jaar |
Lawrence C. Best | M | 75 | 15 jaar | |
Ernest Mario | M | 85 | 15 jaar | |
Arthur Rosenthal | M | 77 | 11 jaar | |
David W. McFaul | M | 67 | - | |
Bruce L. Byrnes | M | 75 | 6 jaar | |
Stephen F. Moreci | M | 72 | 23 jaar | |
Uwe E. Reinhardt | M | 87 | 13 jaar | |
Mary E. Russell | M | 68 | 6 jaar | |
Jim M. Shapiro | M | 65 |
TranS1, Inc.
TranS1, Inc. Medical SpecialtiesHealth Technology TranS1, Inc. designs and develops surgical procedures and equipment for back pain. It is a medical device company focused on designing, developing and marketing products that implement its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region. TranS1 currently markets the AxiaLIF family of products for single-level and two-level lumbar fusion and the Vectre and Avatar posterior fixation systems for lumbar fixation supplemental to AxiaLIF fusion. Its primary technology is AxiaLIF, a minimally invasive access and fusion system that enables lumbar fusion to be performed with complete preservation of the annulus and all paraspinal soft tissue structures. The company specializes in bringing innovative spine solutions to market, including AxiaLIF and AxiaLIF 2L+, technologies that allow surgeons to perform lower lumbar fusions that result in high fusion rates and low complication rates. The company is also developing a motion preservation platform to be delivered through this minimally invasive, trans-sacral approach. TranS1 was founded in May 2000 and is headquartered in Wilmington, NC. | 8 jaar |
Bryan McDonough | M | - | 14 jaar | |
Yi Qun Wang | M | 59 | 18 jaar | |
Paul Douglas Wilson | M | 71 | - | |
Rick Feiler | M | 64 |
TranS1, Inc.
TranS1, Inc. Medical SpecialtiesHealth Technology TranS1, Inc. designs and develops surgical procedures and equipment for back pain. It is a medical device company focused on designing, developing and marketing products that implement its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region. TranS1 currently markets the AxiaLIF family of products for single-level and two-level lumbar fusion and the Vectre and Avatar posterior fixation systems for lumbar fixation supplemental to AxiaLIF fusion. Its primary technology is AxiaLIF, a minimally invasive access and fusion system that enables lumbar fusion to be performed with complete preservation of the annulus and all paraspinal soft tissue structures. The company specializes in bringing innovative spine solutions to market, including AxiaLIF and AxiaLIF 2L+, technologies that allow surgeons to perform lower lumbar fusions that result in high fusion rates and low complication rates. The company is also developing a motion preservation platform to be delivered through this minimally invasive, trans-sacral approach. TranS1 was founded in May 2000 and is headquartered in Wilmington, NC. | 7 jaar |
Doug P. Killion | M | - |
SSI Liquidation Corp.
SSI Liquidation Corp. Wholesale DistributorsDistribution Services SSI Liquidation Corp. distributes sealing products. The company is headquartered in Newtown, PA. | - |
Conor Kilroy | M | 42 | 1 jaar | |
Philip Ebeling | M | 54 | - | |
Isaac Zacharias | M | 49 | 7 jaar | |
Marta Antonucci | M | - | 3 jaar | |
Mark Toland | M | 55 | 19 jaar | |
Nora Dutta | F | - | 8 jaar | |
Kenneth Daignault | M | - | 14 jaar | |
Douglas Teany | M | 52 | 7 jaar | |
Andrew N. Milani | M | 64 | - | |
Stephen D. Ainsworth | M | 54 |
TranS1, Inc.
TranS1, Inc. Medical SpecialtiesHealth Technology TranS1, Inc. designs and develops surgical procedures and equipment for back pain. It is a medical device company focused on designing, developing and marketing products that implement its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region. TranS1 currently markets the AxiaLIF family of products for single-level and two-level lumbar fusion and the Vectre and Avatar posterior fixation systems for lumbar fixation supplemental to AxiaLIF fusion. Its primary technology is AxiaLIF, a minimally invasive access and fusion system that enables lumbar fusion to be performed with complete preservation of the annulus and all paraspinal soft tissue structures. The company specializes in bringing innovative spine solutions to market, including AxiaLIF and AxiaLIF 2L+, technologies that allow surgeons to perform lower lumbar fusions that result in high fusion rates and low complication rates. The company is also developing a motion preservation platform to be delivered through this minimally invasive, trans-sacral approach. TranS1 was founded in May 2000 and is headquartered in Wilmington, NC. | 11 jaar |
Mukesh Ramchandani | M | 58 |
TranS1, Inc.
TranS1, Inc. Medical SpecialtiesHealth Technology TranS1, Inc. designs and develops surgical procedures and equipment for back pain. It is a medical device company focused on designing, developing and marketing products that implement its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region. TranS1 currently markets the AxiaLIF family of products for single-level and two-level lumbar fusion and the Vectre and Avatar posterior fixation systems for lumbar fixation supplemental to AxiaLIF fusion. Its primary technology is AxiaLIF, a minimally invasive access and fusion system that enables lumbar fusion to be performed with complete preservation of the annulus and all paraspinal soft tissue structures. The company specializes in bringing innovative spine solutions to market, including AxiaLIF and AxiaLIF 2L+, technologies that allow surgeons to perform lower lumbar fusions that result in high fusion rates and low complication rates. The company is also developing a motion preservation platform to be delivered through this minimally invasive, trans-sacral approach. TranS1 was founded in May 2000 and is headquartered in Wilmington, NC. | 5 jaar |
John F. Maroney | M | - | 9 jaar | |
Karen T. Boylan | F | 52 | 16 jaar | |
Glendon French | M | 62 | 2 jaar | |
Deborah Defilippo | F | - |
FlowCardia, Inc.
FlowCardia, Inc. Medical SpecialtiesHealth Technology FlowCardia, Inc. designs, develops and manufactures endovascular devices. It offers flowmate Injector to optimize the performance of crosser cto recanalization and crosser catheter, a minimally-invasive endovascular device. The firm also provides portfolio of catheter-based technologies to facilitate guidewire crossing of totally occluded coronary and peripheral arteries. The company was founded by Henry Nita and Erik T. Engelson in 2001 and is headquartered in Sunnyvale, CA. | - |
Kathleen Karloff | F | 69 | 14 jaar | |
Rob A. Abrams | M | - | - | |
Paul J. Southworth | M | - | - | |
Mark Page | M | - |
FlowCardia, Inc.
FlowCardia, Inc. Medical SpecialtiesHealth Technology FlowCardia, Inc. designs, develops and manufactures endovascular devices. It offers flowmate Injector to optimize the performance of crosser cto recanalization and crosser catheter, a minimally-invasive endovascular device. The firm also provides portfolio of catheter-based technologies to facilitate guidewire crossing of totally occluded coronary and peripheral arteries. The company was founded by Henry Nita and Erik T. Engelson in 2001 and is headquartered in Sunnyvale, CA. | 5 jaar |
Daniel Moore | M | 63 | 18 jaar | |
Arthur Franken | M | - |
FlowCardia, Inc.
FlowCardia, Inc. Medical SpecialtiesHealth Technology FlowCardia, Inc. designs, develops and manufactures endovascular devices. It offers flowmate Injector to optimize the performance of crosser cto recanalization and crosser catheter, a minimally-invasive endovascular device. The firm also provides portfolio of catheter-based technologies to facilitate guidewire crossing of totally occluded coronary and peripheral arteries. The company was founded by Henry Nita and Erik T. Engelson in 2001 and is headquartered in Sunnyvale, CA. | - |
Paul Donovan | M | 68 | - | |
Frank Gentile | M | - |
FlowCardia, Inc.
FlowCardia, Inc. Medical SpecialtiesHealth Technology FlowCardia, Inc. designs, develops and manufactures endovascular devices. It offers flowmate Injector to optimize the performance of crosser cto recanalization and crosser catheter, a minimally-invasive endovascular device. The firm also provides portfolio of catheter-based technologies to facilitate guidewire crossing of totally occluded coronary and peripheral arteries. The company was founded by Henry Nita and Erik T. Engelson in 2001 and is headquartered in Sunnyvale, CA. | - |
Gregory Covino | M | 59 | 4 jaar | |
Juan Diaz-Cartelle | M | - | 14 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 99 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Mark T. Stautberg
- Persoonlijk netwerk